HIPERTENSÃO ARTERIAL SISTÊMICA EM GATOS
Parole chiave:
Cardiovascular, felino, lesão de órgão-alvo, pressão arterialAbstract
A hipertensão arterial sistólica é frequentemente reconhecida na prática clínica da medicina interna felina, sendo um problema comum em gatos mais velhos. Esta enfermidade é, costumeiramente, secundária a outras doenças, tais como, doença renal crônica e hipertireoidismo. No entanto, em alguns pacientes a causa subjacente não é identificada, portanto denominada de hipertensão idiopática. Elevações na pressão arterial, de forma sustentada ou não, podem levar a danos em diversos órgãos como, cérebro, olhos, coração e rins. Essas injúrias são denominadas de lesão de órgãos-alvo. Pressão arterial sistêmica acima de 160mmHg possue risco moderado a grave de dano aos órgãos-alvo. Desta maneira, o tratamento procura idealmente atingir riscos de dano mínimos. Alguns fármacos podem ser utilizados como terapia anti-hipertensiva, dentre elas, a amlodipina, um bloqueador de canal de cálcio, que é o medicamento de primeira escolha para tratamento em gatos. Além disso, é de extrema importância o diagnóstico de doenças que possam gerar o quadro hipertensivo ou estar em associação para que desta forma seja possível um controle adequado da pressão arterial. O diagnóstico precoce da doença é fundamental pois auxilia reduzir as chances de lesão nos órgãos-alvo, e consequentemente, reduz a mortalidade e melhora a qualidade de vida dos pacientes.
Riferimenti bibliografici
ACIERNO, M.J.; BROWN, S.; COLEMAN, A.E.; JEPSON, R.E.; PAPICH, M.; STEPIEN, R.L.; SYME, H.M. ACVIM consensus statement: Guidelines for theidentification, evaluation, and management ofsystemichypertension in dogs andcatsJournalofVeterinaryInternal Medicine, v.32, n.6, p.1803-1822, 2018.
BIJSMANS, E.S.; JEPSON, R.E.; CHANG, Y.M.; SYME, H.M.; ELLIOTT, J. Changes in SystolicBloodPressure over Time in Healthy Cats and Cats withChronicKidneyDisease. J VetIntern Med, v.29, n.3, p. 855–861, 2015.
BIJSMANS, E.S.; DOING, M.; JEPSON, R.E.; SYME, H.M.; ELLIOTT, J.; PELLIGAND, L. FactorsInfluencingtheRelationshipBetweenthe Dose ofAmlodipineRequired for BloodPressureControlandChange in BloodPressure in Hypertensive Cats. Journal of VeterinaryInternal Medicine, v.30, n.5, p.1630–1636, 2016.
BIJSMANS, E.S.; JEPSON, R.E., WHEELER, C.; SYME, H.M.; ELLIOTT, J. Plasma N-Terminal ProbrainNatriureticPeptide, Vascular EndothelialGrowth Factor, andCardiacTroponin I as Novel BiomarkersofHypertensiveDiseaseand Target OrganDamage in Cats. Journal of VeterinaryInternal Medicine, v.31, n.3, p.650–660, 2017.
CARTER, J.; IRVING, A.; BRIDGES, J.; JONES, B. The prevalenceof ocular lesionsassociatedwithhypertension in a populationofgeriatriccats in Auckland, New Zealand. New Zealand VeterinaryJournal, v.62, n.1, p.21–29, 2014.
CHETBOUL, V.; LEFEBVRE, H.P.; PINHAS, C.; CLERC, B., BOUSSOUF, M.; POUCHELON, J.L. SpontaneousFelineHypertension: ClinicalandEchocardiographicAbnormalities, andSurvival Rate. Journal of VeterinaryInternal Medicine, v.17, n.1, p.89–95, 2003.
COLE, L.; JEPSON, R.; HUMM, K. Systemichypertension in catswithacutekidneyinjury. JournalofSmall Animal Practice, v.58, n.10, p.577-581, 2017.
COLEMAN, A.E.; BROWN, S.A.; STARK, M.; BRYSON, L.; ZIMMERMAN, A.; ZIMMERING, T.; TRAAS, A.M. Evaluationoforallyadministeredtelmisartan for thereductionofindirectsystolic arterial bloodpressure in awake, clinically normal cats. JournalofFeline Medicine andSurgery, v.21, n.2, p.1-6, 2018.
CONROY, M.; CHANG, Y.M.; BRODBELT, D.; ELLIOTT, J. Survivalafterdiagnosisofhypertension in catsattendingprimarycarepractice in the United Kingdom. Journal of VeterinaryInternal Medicine, v.32, n.6, p.1846-1855, 2018.
DAVY, K.P.; HALL, J.E. Obesityandhypertension: Twoepidemicsorone? American JournalPhysiologyRegulatory, IntegrativeandComparativePhysiology, v.286, n.5, p.803–813, 2004.
DESMET, L.; MEER, J.V.D. Antihypertensivetreatmentwithtelmisartan in a catwithamlodipine-inducedgingivalhyperplasia. JournalofFeline Medicine andSurgery Open Reports, v.3, n.2, p.1-5, 2017.
FERREIRA, A.; SOTTIAUX, J.; MANDARA, M.T.; MOTTA, L. Ascendinghaemorrhagicmyelomalaciaassociatedwithsystemichypertension in a hyperthyroid cat. JournalofFeline Medicine andSurgery Open Reports, v.1, n.1, p.1-6, 2015.
GLAUS, T.M.; ELLIOTT, J.; HERBERICH, E.; ZIMMERING, T.; ALBRECHT, B. Efficacyoflong-term oral telmisartantreatment in catswithhypertension: Resultsof a prospectiveEuropeanclinicaltrial. Journal of VetrinaryInternal Medicine, v.33, n.2, p.413-422, 2019.
GOUNI, V.; TISSIER, R.; MISBACH, C.; BALOUKA, D.; BUENO, H.; POUCHELON, J.; LEFEBVRE, H.P.; CHETBOUL, V. Influenceoftheobserver’slevelofexperience on systolicanddiastolic arterial bloodpressuremeasurementsusing Doppler ultrasonography in healthyconsciouscats. JournalofFeline Medicine andSurgery, v.17, v.2, p.94-100, 2015.
HENIK, R.A.; STEPIEN, R.L.; WENHOLZ, L.J.; DOLSON, M.K. Efficacyof atenolol as a single antihypertensiveagent in hyperthyroidcats. JournalofFeline Medicine andSurgery, v.10, n.6, p.577-582, 2008.
Randomized Placebo-ControlledClinicalTrialof a Chewable
FormulationofAmlodipine for theTreatmentofHypertension in
Client-Owned Cats
Randomized Placebo-ControlledClinicalTrialof a Chewable
FormulationofAmlodipine for theTreatmentofHypertension in
Client-Owned Cats
Randomized Placebo-ControlledClinicalTrialof a Chewable
FormulationofAmlodipine for theTreatmentofHypertension in
Client-Owned Cats
Randomized Placebo-ControlledClinicalTrialof a Chewable
FormulationofAmlodipine for theTreatmentofHypertension in
Client-Owned Cats
Randomized Placebo-ControlledClinicalTrialof a Chewable
FormulationofAmlodipine for theTreatmentofHypertension in
Client-Owned Cats
Randomized Placebo-ControlledClinicalTrialof a Chewable
FormulationofAmlodipine for theTreatmentofHypertension in
Client-Owned Cats
HUHTINEN, M.; DERRÉ, G.; RENOLDI, H.J.; RINKINEN, M.; ADLER, K.; ASPEGUÉN, J.; ZEMIRLINE, C.; ELLIOTT, J. Randomized Placebo-ControlledClinicalTrialof a ChewableFormulationofAmlodipine for theTreatmentofHypertension in Client-Owned Cats. Journal of VeterinaryInternal Medicine, v.29, n.3, p.786-793, 2015.
JENKINS, T.L.; COLEMAN, A.E.; SCHMIEDT, C.W.; BROWN, S.A. Attenuationofthe pressor response toexogenousangiotensinbyangiotensin receptor blockersandbenazeprilhydrochloride in clinically normal cats. American Journal of VeterinaryResearch, v.76, n.9, p.807-813, 2015.
JEPSON, R.E.; ELLIOTT, J.; BRODBELT, D.; SYME, H.M. Effectofcontrolofsystolicbloodpressure on survival in catswithsystemichypertension. Journal of VeterinaryInternal Medicine, v.21, n.3, p.402-409, 2007.
Guidelines for theIdentification, Evaluation, and Management of
SystemicHypertension in Dogs and Cats
Guidelines for theIdentification, Evaluation, and Management of
SystemicHypertension in Dogs and Cats
Guidelines for theIdentification, Evaluation, and Management of
SystemicHypertension in Dogs and Cats
Guidelines for theIdentification, Evaluation, and Management of
SystemicHypertension in Dogs and Cats
JEPSON, R.E. Felinesystemichypertension: classificationandpathogenesis. JournalofFeline Medicine andSurgery, v.13, n.1, p.25–34, 2011.
KOHNKEN, R.; SCANSEN, B.A.; PREMANANDAN, C. Vasa VasorumArteriopathy: RelationshipWithSystemic Arterial Hypertensionand Other Vascular Lesions in Cats. VeterinaryPathology, v.54, n.3, p.475–483, 2016.
MAGGIO, F.; DEFRANCESCO, T.C.; ATKINS, C.E.; PIZZIRANI, S.; GILGER B.C.; DAVIDSON, M.G. Ocular lesionsassociatedwithsystemichypertension in cats: 69 cases (1985-1998). Journalofthe American Veterinary Medical, v.217, n.5, p.695–702, 2000.
O’NEILL, J.; KENT, M.; GLASS, E.N.; PLATT, S.R. Clinicopathologicand MRI CharacteristicsofPresumptiveHypertensiveEncephalopathy in Two Cats andTwo Dogs. Journal of the American Animal Hospital Association, v.49, n.6, p.412–420, 2013.
PAYNE, J.R.; BRODBELT, D.C.; FUENTES, V.L. BloodPressureMeasurements in 780 ApparentlyHealthy Cats. Journal of VeterinaryInternal Medicine, v.31, n.1, p.15-21, 2017.
RITMAN EL; LERNAN A. The dynamic vasa vasorum. Cardiovascular Research, v.75, n.4, p.649–658, 2007.
SENT, U.; GOSSL R.; ELLIOTT, J.; SYME, H.M.; ZIMMERING, T. Comparisonofefficacyoflong-term oral treatmentwithtelmisartanandbenazepril in catswithchronickidneydisease. Journal of VeterinaryInternal Medicine, v.29, n.6, p.1479-1487, 2015.
STEELE, J.L.; HENIK, R.A.; STEPIEN, R.L. Effectsofangiotensin-convertingenzymeinhibition on plasma aldosteroneconcentration, plasma reninactivity, andbloodpressure in spontaneouslyhypertensivecatswithchronic renal disease. Veterinarytherapeutics: research in appliedveterinary medicine, v.3, n.2, p.157-166, 2002.
WILLIAMS, T.L.; ELLIOTT, J.; SYME, H.M. Renin-Angiotensin-Aldosterone System Activity in Hyperthyroid Cats withandwithoutConcurrentHypertension. Journal of VeterinaryInternal Medicine, v.27, n.3, p.522–529, 2013.
